AIM IP specialist Tekcapital to sell or float all four portfolio companies 'within 2 years'. Watch the full video here

Less Ads, More Data, More Tools Register for FREE

AstraZeneca COVID-19 vaccine could be on the market by end of 2020 - Italy minister

Wed, 2nd Sep 2020 15:38

ROME, Sept 2 (Reuters) - The first shots of British drug
maker AstraZeneca's potential COVID-19 vaccine could be
on the market by the end of 2020, Italian Health Minister
Roberto Speranza said on Wednesday.

"We are talking about a potential vaccine so we need to be
extremely prudent, but... if the vaccine is confirmed as safe
and able to meet its objective it will be already available by
the end of 2020," Speranza told parliament.

Drugmakers are racing to combat the pandemic, which has
killed more than 850,000 people and infected over 25 million.

The European Commission has paid 336 million euros ($397.82
million) to AstraZeneca to secure at least 300 million doses of
its potential vaccine for EU nations.
($1 = 0.8446 euros)
(Reporting by Angelo Amante; Editing by Crispian Balmer)

Related Shares

More News

Sunday newspaper round-up: AstraZeneca, Virgin Atlantic, Boohoo

(Sharecast News) - AstraZeneca boss Pascal Soriot was last night at the centre of an extraordinary row among City investors over his multi-million-pound bonus. The French chief executive has been lauded for rolling out Astra's life-saving Covid vaccine at no profit, as well as fighting off predatory buyers and boosting the company's share price since he took charge in 2012. But Astra's major shareholders are understood to have been locked in heated talks for days after the drugs giant proposed to boost his bonus and performance-related share award by £2.3million to £12million. - Financial Mail on Sunday

9 May 21 20:21

UK to give under 40s alternative to AstraZeneca vaccine

(Sharecast News) - The UK government decided on Friday to offer people under 40 an alternative to the AstraZeneca Covid-19 vaccine, reported Bloomberg.

7 May 21 09:49

All under-40s to be offered alternative to AstraZeneca vaccine

All under-40s to be offered alternative to AstraZeneca vaccine

7 May 21 08:49

AstraZeneca reports positive results in Phase 3 lung cancer drug trial

AstraZeneca reports positive results in Phase 3 lung cancer drug trial

7 May 21 08:32

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.